These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35628323)

  • 1. Behavioral Evidence for a Tau and HIV-gp120 Interaction.
    Vijayan M; Yin L; Reddy PH; Benamar K
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of Cerebrospinal Fluid Alzheimer's Dementia Biomarkers in People Living with HIV: Cross-Sectional Study on Associated Factors According to Viral Control, Neurological Confounders and Neurocognition.
    Trunfio M; Atzori C; Pasquero M; Di Stefano A; Vai D; Nigra M; Imperiale D; Bonora S; Di Perri G; Calcagno A
    Viruses; 2022 Apr; 14(4):. PubMed ID: 35458483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased glial and synaptic glutamate uptake in the striatum of HIV-1 gp120 transgenic mice.
    Melendez RI; Roman C; Capo-Velez CM; Lasalde-Dominicci JA
    J Neurovirol; 2016 Jun; 22(3):358-65. PubMed ID: 26567011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.
    Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D
    J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV and FIV glycoproteins increase cellular tau pathology via cGMP-dependent kinase II activation.
    Sathler MF; Doolittle MJ; Cockrell JA; Nadalin IR; Hofmann F; VandeWoude S; Kim S
    J Cell Sci; 2022 Jun; 135(12):. PubMed ID: 35638570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoietin plus insulin-like growth factor-I protects against neuronal damage in a murine model of human immunodeficiency virus-associated neurocognitive disorders.
    Kang YJ; Digicaylioglu M; Russo R; Kaul M; Achim CL; Fletcher L; Masliah E; Lipton SA
    Ann Neurol; 2010 Sep; 68(3):342-52. PubMed ID: 20818790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aging, comorbidities, and the importance of finding biomarkers for HIV-associated neurocognitive disorders.
    Rosenthal J; Tyor W
    J Neurovirol; 2019 Oct; 25(5):673-685. PubMed ID: 30868422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sirtuin-2, NAD-Dependent Deacetylase, Is a New Potential Therapeutic Target for HIV-1 Infection and HIV-Related Neurological Dysfunction.
    Duran-Castells C; Llano A; Kawana-Tachikawa A; Prats A; Martinez-Zalacain I; Kobayashi-Ishihara M; Oriol-Tordera B; Peña R; Gálvez C; Silva-Arrieta S; Clotet B; Riveira-Muñoz E; Ballana E; Prado JG; Martinez-Picado J; Sanchez J; Mothe B; Hartigan-O'Connor D; Wyss-Coray T; Meyerhans A; Gisslén M; Price RW; Soriano-Mas C; Muñoz-Moreno JA; Brander C; Ruiz-Riol M
    J Virol; 2023 Feb; 97(2):e0165522. PubMed ID: 36719240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of methamphetamine and HIV-1 gp120 causes distinct long-term alterations of behavior, gene expression, and injury in the central nervous system.
    Hoefer MM; Sanchez AB; Maung R; de Rozieres CM; Catalan IC; Dowling CC; Thaney VE; Piña-Crespo J; Zhang D; Roberts AJ; Kaul M
    Exp Neurol; 2015 Jan; 263():221-34. PubMed ID: 25246228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APOE ε4 moderates abnormal CSF-abeta-42 levels, while neurocognitive impairment is associated with abnormal CSF tau levels in HIV+ individuals - a cross-sectional observational study.
    Cysique LA; Hewitt T; Croitoru-Lamoury J; Taddei K; Martins RN; Chew CS; Davies NN; Price P; Brew BJ
    BMC Neurol; 2015 Apr; 15():51. PubMed ID: 25880550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linked CSF reduction of phosphorylated tau and IL-8 in HIV associated neurocognitive disorder.
    Ozturk T; Kollhoff A; Anderson AM; Christina Howell J; Loring DW; Waldrop-Valverde D; Franklin D; Letendre S; Tyor WR; Hu WT
    Sci Rep; 2019 Jun; 9(1):8733. PubMed ID: 31217522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mediational effects of FDG hypometabolism on the association between cerebrospinal fluid biomarkers and neurocognitive function.
    Dowling NM; Johnson SC; Gleason CE; Jagust WJ;
    Neuroimage; 2015 Jan; 105():357-68. PubMed ID: 25450107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.
    Mandecka M; Budziszewska M; Barczak A; Pepłońska B; Chodakowska-Żebrowska M; Filipek-Gliszczyńska A; Nesteruk M; Styczyńska M; Barcikowska M; Gabryelewicz T
    J Alzheimers Dis; 2016 Jul; 54(1):157-68. PubMed ID: 27472875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular Vesicles: A Possible Link between HIV and Alzheimer's Disease-Like Pathology in HIV Subjects?
    Kodidela S; Gerth K; Haque S; Gong Y; Ismael S; Singh A; Tauheed I; Kumar S
    Cells; 2019 Aug; 8(9):. PubMed ID: 31450610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers of neuronal injury and amyloid metabolism in the cerebrospinal fluid of patients infected with HIV-1 subtypes B and C.
    de Almeida SM; Ribeiro CE; Rotta I; Piovesan M; Tang B; Vaida F; Raboni SM; Letendre S; Potter M; Batistela Fernandes MS; Ellis RJ;
    J Neurovirol; 2018 Feb; 24(1):28-40. PubMed ID: 29063514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlations between cerebrospinal fluid biomarkers, neurocognitive tests, and resting-state electroencephalography (rsEEG) in patients with HIV-associated neurocognitive disorders.
    Barco A; Orlando S; Stroffolini G; Pirriatore V; Lazzaro A; Vai D; Guastamacchia G; Noce G; Atzori C; Trunfio M; Bonora S; Di Perri G; Calcagno A
    J Neurovirol; 2022 Apr; 28(2):226-235. PubMed ID: 35044644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does HIV infection contribute to increased beta-amyloid synthesis and plaque formation leading to neurodegeneration and Alzheimer's disease?
    Fulop T; Witkowski JM; Larbi A; Khalil A; Herbein G; Frost EH
    J Neurovirol; 2019 Oct; 25(5):634-647. PubMed ID: 30868421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Subjective Cognitive Decline with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology in Cognitively Intact Older Adults: The CABLE Study.
    Wen C; Bi YL; Hu H; Huang SY; Ma YH; Hu HY; Tan L; Yu JT
    J Alzheimers Dis; 2022; 85(3):1143-1151. PubMed ID: 34924386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer's disease.
    Gangishetti U; Christina Howell J; Perrin RJ; Louneva N; Watts KD; Kollhoff A; Grossman M; Wolk DA; Shaw LM; Morris JC; Trojanowski JQ; Fagan AM; Arnold SE; Hu WT
    Alzheimers Res Ther; 2018 Sep; 10(1):98. PubMed ID: 30253800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive impairment in late-life bipolar disorder is not associated with Alzheimer's disease pathological signature in the cerebrospinal fluid.
    Forlenza OV; Aprahamian I; Radanovic M; Talib LL; Camargo MZ; Stella F; Machado-Vieira R; Gattaz WF
    Bipolar Disord; 2016 Feb; 18(1):63-70. PubMed ID: 26876913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.